1. Home
  2. CBK vs CMPX Comparison

CBK vs CMPX Comparison

Compare CBK & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CBK

Commercial Bancgroup Inc.

HOLD

Current Price

$33.43

Market Cap

392.4M

Sector

Finance

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$2.25

Market Cap

371.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBK
CMPX
Founded
1975
2014
Country
United States
United States
Employees
298
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
392.4M
371.0M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CBK
CMPX
Price
$33.43
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$14.57
AVG Volume (30 Days)
93.5K
3.3M
Earning Date
04-27-2026
05-06-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.67
N/A
Revenue Next Year
$8.05
$934.41
P/E Ratio
$9.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$23.24
$1.61
52 Week High
$33.83
$6.88

Technical Indicators

Market Signals
Indicator
CBK
CMPX
Relative Strength Index (RSI) 74.59 54.71
Support Level $23.90 $1.88
Resistance Level N/A $2.47
Average True Range (ATR) 0.83 0.10
MACD 0.14 0.06
Stochastic Oscillator 87.35 93.94

Price Performance

Historical Comparison
CBK
CMPX

About CBK Commercial Bancgroup Inc.

Commercial Bancgroup Inc is a bank holding company. Through its subsidiary, it operates as a full-service community banking institution offering traditional consumer and commercial products and services to businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. In Tennessee, its service areas include the metropolitan statistical areas of Nashville Davidson, Murfreesboro, Franklin, Knoxville, and the Tri Cities region of Kingsport, Bristol, and Johnson City, as well as Claiborne County, Cocke County, Union County, Hamblen County, and their surrounding areas.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: